Geftib Tablet
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Gefitinib (250mg)
Overview Geftib Tablet
Geftib tablets treat advanced non-small cell lung cancer. This medication is for patients with metastatic disease, abnormal epidermal growth factor receptor (EGFR) genes, and no prior cancer treatment. Dosage and duration are determined by your physician. Consistent use, as prescribed, is crucial. Regular liver function checks may be recommended. Common side effects include nausea, diarrhea, dry skin, and appetite loss. Increased fluid intake may mitigate some side effects. Report any concerning or worsening side effects to your doctor immediately. Seek immediate medical attention for mouth sores, vision changes, or breathing problems. Women should employ effective contraception during treatment and for one month afterward to prevent pregnancy. Always inform your doctor of all other medications you are currently using.
Uses of Geftib Tablet
Lung cancer (excluding small cell type)
Major Benefits of Geftib Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Geftib Tablet can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Geftib Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Geftib Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Geftib Tablet whole; do not chew, crush, or divide it. While Geftib Tablet can be taken with or without food, consistent timing is recommended.
How Geftib Tablet works:
Geftib tablets are a cancer treatment that inhibits the activity of a faulty protein responsible for triggering uncontrolled cancer cell growth, thus hindering or delaying the progression of the disease.
SAFETY ADVICE
AlcoholUNSAFE
Combining Geftib Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Geftib Tablet during pregnancy is contraindicated due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Geftib Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Geftib Tablet side effects.
KidneyCAUTION
Patients with severe kidney impairment should use Geftib Tablet cautiously, as dose modification may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Geftib Tablet in patients with liver impairment appears to be safe. Current evidence indicates dose modification may not be necessary, but physician consultation is recommended.
What if you forget to take Geftib Tablet :
Omit a missed Geftib Tablet dose; resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Geftib Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline amines |
| Developing Habits | No. |
| Type of Therapy | Cancer Treatments |
3,018 People bought this recently